UNC-Duke Collaborative Clinical Pharmacology T32 Postdoctoral Training Program
The UNC-Duke Collaborative Clinical Pharmacology T32 Postdoctoral Training Program and the Duke-UNC Collaborative Pediatric Clinical Pharmacology T32 Postdoctoral Training Program are a collaboration between the University of North Carolina at Chapel Hill and Duke University. The overarching goal of these two-year programs is to cultivate a new generation of translational scientists equipped to address critical problems in adult and pediatric clinical pharmacology. Trainees, guided by individualized development plans and mentoring teams, complete clinical pharmacology coursework and engage in program-specific activities to gain expertise in all aspects of contemporary clinical pharmacology research in preparation for successful academic, regulatory, or industrial careers as leaders and mentors to future generations of clinical pharmacologists. Four focus areas form the core of these training programs:
- Drug Disposition and Action
- Quantitative Pharmacology/Pharmacometrics & Clinical Trial Design
- Individualized Therapy
- Drug-induced Organ Toxicity
Unique features of this training program include a focus on precision dosing, use of real-world data, and pharmacometrics. This program is supported by the National Institute of General Medical Sciences (NIGMS) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) under award numbers T32 GM086330 and T32 HD104576. The programs are accredited by the American Board of Clinical Pharmacology (ABCP).